LAMF Global Ventures Corp. I entered into Warrant Assignment, Assumption and Amendment Agreement with Continental Stock Transfer & Trust Company valued at Entry into Warrant Assignment, Assumption and Amendment Agreement assigning existing warrant agreeme (effective 2024-04-30).
“On April 30, 2024, LAMF, Holdco and Continental Stock Transfer & Trust Company (“Continental”) entered into that certain Warrant Assignment, Assumption and Amendment Agreement (the “New Warrant Agreement”).”
Rubicon Technologies, Inc.
Rubicon Technologies, Inc. entered into Securities Purchase Agreement with MBI Holdings, LP valued at aggregate purchase price of $20,000,000 (effective 2024-05-07).
“On May 7, 2024, the Company entered into a Securities Purchase Agreement (the “ Purchase Agreement ”), by and between the Company and MBI Holdings, LP (the “ Buyer ”), an affiliate of Rodina.”
Rubicon Technologies, Inc.
Rubicon Technologies, Inc. entered into Asset Purchase Agreement with Wastech Corp. valued at approximate aggregate purchase price of $68,000,000 (effective 2024-05-07).
“On May 7, 2024, Rubicon Technologies, Inc. (the “ Company ”), a company incorporated under the laws of the State of Delaware, entered into an Asset Purchase Agreement (the “ Asset Purchase Agreement ”) by and among the Company , Rubicon Technologies Holdings, LLC, a Delaware limited liability company (“ Holdings ”), Wastech Corp. (“ Wastech ”), an affiliate of Rodina Capital (“ Rodina ”), and, solely for purposes of guaranteeing certain obligations of Wastech under the Asset Purchase Agreement, GAFAPA, S.A. de C.V., an affiliate of Rodina.”
Invest Acquisition Corp
Invest Acquisition Corp amended Third Amendment to the Business Combination Agreement with Pubco, OpSec and the OpSec Shareholders (effective 2024-05-03).
“On May 3, 2024, the Company entered into that certain Third Amendment to the Business Combination Agreement (the “Third BCA Amendment” and, the Original Business Combination Agreement, as amended by the First BCA Amendment, the Second BCA Amendment and the Third BCA Amendment, the “Business Combination Agreement”) with Pubco, OpSec and the OpSec Shareholders.”
FRBPFranklin BSP Capital Corp
Franklin BSP Capital Corp entered into Registration Rights Agreement with J.P. Morgan Securities LLC, BofA Securities, Inc., SMBC Nikko Securities America, Inc. and Wells Fargo Securities, LLC (effective 2024-05-06).
“In connection with the Notes Offering, the Company entered into a Registration Rights Agreement, dated as of May 6, 2024 (the “Registration Rights Agreement”), with J.P. Morgan Securities LLC, BofA Securities, Inc., SMBC Nikko Securities America, Inc. and Wells Fargo Securities, LLC, as the representatives of the initial purchasers of the Notes.”
FRBPFranklin BSP Capital Corp
Franklin BSP Capital Corp entered into Third Supplemental Indenture with U.S. Bank Trust Company, National Association valued at $300,000,000 aggregate principal amount (effective 2024-05-06).
“On May 6, 2024, Franklin BSP Capital Corporation (the “Company”) and U.S. Bank Trust Company, National Association (the “Trustee”) entered into a Third Supplemental Indenture (the “Third Supplemental Indenture”) to the Indenture, dated as of March 29, 2021, between the Company and the Trustee (the “Base Indenture” and, together with the Third Supplemental Indenture, the “Indenture”).”
Leafly Holdings, Inc. /DE
Leafly Holdings, Inc. /DE amended Notice with each of the holders of the Note (effective 2024-05-07).
“On May 7, 2024, Leafly Holdings, Inc. (the “Company”) and each of the holders (each a “Holder” and collectively, the “Holders”) of that certain global note representing 8.00% Convertible Senior Notes due 2025 between the Company, Ankura Trust Company, as agent, and Continental Stock Transfer & Trust Company, as authentication agent, dated February 4, 2022 (the “Note”) executed a notice of conversion and consent (the “Notice”) to effect a temporary and limited adjustment to the conversion price under the Note.”
Synergy Empire Ltd
Synergy Empire Ltd entered into Purchase Agreement with Michael Tan and Andy Choe valued at $100,000 (effective 2024-05-01).
“On May 1, 2024, Synergy Empire Limited (the “ Company ”) entered into a Regulation S Stock Purchase Agreement (the “ Purchase Agreement ”) with two investors, Michael Tan and Andy Choe (collectively, the “ Investors ”), relating to the sale by the Company of an aggregate of 500,000 shares of the Company’s common stock, $.0001 par value per share (the “ Common Stock ”) at a price of $0.20 per share.”
AGILITI, INC. \DE
AGILITI, INC. \DE amended First Amendment with the Borrower, the lenders party thereto, the subsidiary guarantors party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent valued at $400 million (effective 2024-05-07).
“On May 7, 2024, Agiliti Health, Inc. (the “ Borrower ”) and Agiliti Holdco, Inc., each a subsidiary of the Company, and certain of their subsidiaries, entered into an amendment (the “ First Amendment ”) to the Borrower’s Amended and Restated Credit Agreement, dated May 1, 2023 (as amended, the “ Credit Agreement ”), among the Borrower, the lenders party thereto, the subsidiary guarantors party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent. Among other things, the First Amendment increased the principal amount of initial term loans by $400 million under a new incremental term facility, which otherwise has the same terms as those applicable to the existing initial term loans under the Credit Agreement.”
BACKIMAC Holdings, Inc.
IMAC Holdings, Inc. terminated Agreement and Plan of Merger with Theralink Technologies, Inc. (effective 2024-05-06).
“on May 6, 2024, the Company, IMAC Merger Sub, Inc. (“ Merger Sub ”) and Theralink entered into a Termination Agreement, which immediately terminated the Agreement and Plan of Merger, dated May 26, 2023, by and between the Company, Merger Sub and Theralink”
ADTXAditxt, Inc.
Aditxt, Inc. entered into Common Stock Purchase Agreement with an equity line investor (the 'Investor') valued at $150,000,000 (effective 2024-05-02).
“On May 2, 2024, Aditxt, Inc. (the “ Company ”) entered into a Common Stock Purchase Agreement (the “ Purchase Agreement ”) with an equity line investor (the “ Investor ”), pursuant to which the Investor has agreed to purchase from the Company, at the Company’s direction from time to time, in its sole discretion, from and after the date effective date of the Registration Statement (as defined below) and until the termination of the Purchase Agreement in accordance with the terms thereof, shares of the Company’s common stock having a total maximum aggregate purchase price of $150,000,000”
ENERGY RESOURCES 12, L.P.
ENERGY RESOURCES 12, L.P. entered into Loan Agreement with BancFirst valued at $20 million revolving credit facility, initial borrowing base $10 million (effective 2024-05-02).
“On May 2, 2024, the Partnership and its wholly-owned subsidiary, as borrowers, entered into a loan agreement (“Loan Agreement”) with BancFirst (the “Lender”), which provides for a revolving credit facility (“Credit Facility”) with an approved maximum credit amount (“Maximum Credit Amount”) of $20 million, subject to borrowing base restrictions.”
CRCWCrypto Co
Crypto Co amended First Amendment to that certain Promissory Note with AJB Capital Investments LLC (effective 2024-05-01).
“On May 1, 2024, the Crypto Company (the “Company”) and AJB Capital Investments LLC entered into a First Amendment to that certain Promissory Note dated as of April 12, 2024 (“Existing Note”).”
ALZNAlzamend Neuro, Inc.
Alzamend Neuro, Inc. terminated Agreement with Ascendiant Capital Markets, LLC (effective 2024-05-16).
“Item 1.02 Termination of a Material Agreement On May 6, 2024, Alzamend Neuro, Inc. (the “ Company ”) provided written notice to Ascendiant Capital Markets, LLC, as sales agent (the “ Agent ”) of its election to terminate the At-the-Market (“ ATM ”) Issuance Sales Agreement (the “ Agreement” ), dated September 8, 2023, between the Company and the Agent with regards to sales of the Company’s common stock under the Agreement. The Company had sold 1.08 million shares of common stock and raised approximately $1.3 million in gross proceeds, or approximately $1.20 per share, under the ATM. The termination is effective as of May 16, 2024. The material terms of the Agreement are summarized in the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 8, 2023.”
DBGIDigital Brands Group, Inc.
Digital Brands Group, Inc. entered into Inducement Agreement with accredited investor valued at $3,216,857.50 (effective 2024-05-03).
“On May 3, 2024, the Company entered into that certain inducement offer to exercise common stock purchase warrants with the Investor (the “Inducement Agreement"), pursuant to which (i) the Company agreed to lower the exercise price of the Existing Warrants to $3.13 per share and (ii) the Investor agreed to exercise the Existing Warrants into 1,027,750 shares of Common Stock (the “Exercise Shares") by payment of the aggregate exercise price of $3,216,857.50”
PAVMPAVmed Inc.
PAVmed Inc. entered into Subscription Agreement with certain accredited investors valued at approximately $11.6 million (effective 2024-05-01).
“entered into subscription agreements (each, a “ Subscription Agreement ”) with certain accredited investors (collectively, the “ Investors ”), which agreements provided for the sale to the Investors of approximately 11,634 shares of Lucid Diagnostics’ newly designated Series B-1 Convertible Preferred Stock, par value $0.001 per share (the “ Series B-1 Preferred Stock ”), at a purchase price of $1,000 per share (collectively, the “ Offering ”). The gross proceeds to Lucid Diagnostics of the Offering were approximately $11.6 million.”
GBTCGrayscale Bitcoin Trust ETF
Grayscale Bitcoin Trust ETF amended Amendment No. 2 with CSC Delaware Trust Company (effective 2024-05-07).
“On May 7, 2024, Grayscale Investments, LLC, the sponsor (the “Sponsor”) of Grayscale Bitcoin Trust (BTC) (the “Trust”), and CSC Delaware Trust Company, the trustee (the “Trustee”) of the Trust, entered into Amendment No. 2 ( “Amendment No. 2”) to the Seventh Amended and Restated Declaration of Trust and Trust Agreement, dated as of March 15, 2024, as amended by Amendment No. 1 thereto dated as of March 15, 2024 (the “Seventh A&R Trust Agreement”)”
REALTheRealReal, Inc.
TheRealReal, Inc. entered into Indenture with GLAS Trust Company LLC valued at $135,000,000 (effective 2024-02-29).
“On the Effective Date, in connection with the Exchange Transactions, the Company issued $135,000,000 in aggregate principal amount of New Notes pursuant to that certain Indenture, dated as of the Effective Date (the “Indenture”), by and among the Company, the Guarantors (as defined in the Indenture) party thereto from time to time and GLAS Trust Company LLC, as trustee and notes collateral agent.”
REALTheRealReal, Inc.
TheRealReal, Inc. entered into Exchange Agreements with certain Noteholders valued at $135,000,000 (effective 2024-02-29).
“On February 29, 2024 (the “Effective Date”), the Company entered into private, separately negotiated exchange agreements (collectively, the “Exchange Agreements”) with certain Noteholders (as defined therein), pursuant to which the parties agreed to exchange (i) $145,751,000 in aggregate principal amount of the holders’ 3.00% Convertible Senior Notes due 2025 and (ii) $6,480,000 in aggregate principal amount of the holders’ 1.00% Convertible Senior Notes due 2028 (clauses (i) and (ii) together, the “Exchanged Notes”) for (a) $135,000,000 in aggregate principal amount of the Company’s 4.25%/8.75% PIK/Cash Senior Secured Notes due 2029”
SBEVSPLASH BEVERAGE GROUP, INC.
SPLASH BEVERAGE GROUP, INC. entered into Purchase Agreement with certain accredited investors valued at $1,850,000 (effective 2024-05-01).
“On May 1, 2024, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with certain accredited investors (the “Purchasers”). Pursuant to the Purchase Agreement, the Company sold the Purchasers: (i) senior convertible notes in the aggregate original principal amount of $1,850,000, (the “Notes”) convertible into up to 4,625,000 shares of common stock of the Company, par value $0.001 per share (“Common Stock”), subject to adjustments as provided in the Notes, (ii) 925,000 shares of Common Stock (the “Commitment Shares”), (ii) warrants to initially acquire up to an aggregate of 4,625,000 additional shares of Common Stock (the “Warrants”) at an exercise price of $0.85 per Warrant Share.”
SKWDSkyward Specialty Insurance Group, Inc.
Skyward Specialty Insurance Group, Inc. entered into Underwriting Agreement with Barclays Capital Inc., Keefe, Bruyette & Woods, Inc. and Jefferies LLC as representatives of the several underwriters valued at $36.50 per share (effective 2024-05-06).
“On May 6, 2024, Skyward Specialty Insurance Group, Inc., a Delaware corporation (the “Company”) and Westaim HIIG GP Inc. (the “Selling Stockholder”) entered in an underwriting agreement (the “Underwriting Agreement”) with Barclays Capital Inc., Keefe, Bruyette & Woods, Inc. and Jefferies LLC as representatives of the several underwriters named therein”
BANDBandwidth Inc.
Bandwidth Inc. amended Credit Agreement with Bank of America, N.A., as administrative agent, swingline lender and letters of credit issuer (effective 2024-05-01).
“On May 1, 2024, Bandwidth Inc. (the “Company”) entered into an amendment (the “Credit Agreement Amendment”) to the credit agreement (as amended, the “Credit Agreement”) among the Company, as borrower, certain subsidiaries of the Company, as guarantors, the lenders from time to time party thereto, and Bank of America, N.A., as administrative agent, swingline lender and letters of credit issuer, with BofA Securities, Inc. and Wells Fargo Securities, LLC as Joint Lead Arrangers and Joint Bookrunners.”
AmeriCann, Inc.
AmeriCann, Inc. terminated a lease with BASK, Inc. (effective 2024-05-03).
“☐ 1 ITEM 1.02 TERMINATION OF A MATERIAL DEFINITIVE AGREEMENT On July 26, 2019, the Company entered into a 15-Year Triple Net lease of Building 1 of the Massachusetts Cannabis Center with BASK, Inc. The lease commenced on September 1, 2019 and included a monthly base rent of $11,563.50 and a revenue participation fee equivalent to 15% of BASK’s gross revenues derived from products produced in the building.”
LOOPLoop Industries, Inc.
Loop Industries, Inc. entered into Agreement with Ester Industries Ltd. valued at USD $165 million (effective 2024-05-01).
“On May 1, 2024, Loop Industries, Inc. (the “Company” or “Loop”) entered into an agreement (the “Agreement”) by and between the Company and Ester Industries Ltd. (“Ester”).”
ELDNEledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals, Inc. entered into Registration Rights Agreement with the Purchasers (effective 2024-05-06).
“In connection with the Private Placement, the Company entered into a registration rights agreement, dated May 6, 2024 (the “Registration Rights Agreement”), with the Purchasers, pursuant to which, among other things, the Company will (i) prepare and file with the Securities and Exchange Commission (the “SEC”) a registration statement on Form S-3 to register for resale the Shares and the shares of Common Stock issuable upon the exercise of the Pre-Funded Warrants within 20 calendar days, and (ii) use its reasonable best efforts to have the registration statement declared effective promptly after filing, and in any event no later than 60 days after the date of the Securities Purchase Agreement (or 90 days after the date of the Securities Purchase Agreement if the registration statement is reviewed by the SEC).”
ELDNEledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals, Inc. entered into Securities Purchase Agreement with certain institutional and accredited investors (the "Purchasers") valued at approximately $50 million (effective 2024-05-06).
“On May 6, 2024, Eledon Pharmaceuticals, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain institutional and accredited investors (the “Purchasers”), pursuant to which the Company agreed to issue and sell to the Purchasers in a private placement (the “Private Placement”) an aggregate of 13,110,484 shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”) at a price of $2.37 per share, and pre-funded warrants (the “Pre-Funded Warrants”) at a price of $2.369 per underlying share, which are exercisable to purchase 7,989,516 shares of Common Stock at an exercise price of $0.001 per share.”
DWAYDriveitaway Holdings, Inc.
Driveitaway Holdings, Inc. entered into Credit Facility with an investor (the "Lender") valued at $2,000,000 line of credit (effective 2024-03-01).
“On March 1, 2024, DIA Leasing, LLC. (the "Borrower"), a direct wholly owned subsidiary of DriveitAway Holdings, Inc. ("DWAY"), closed a $2,000,000 line of credit facility (the "Credit Facility") with an investor (the "Lender").”
AMYRIS, INC.
AMYRIS, INC. terminated DIP Credit Agreement with Euagore, LLC valued at DIP Credit Agreement was amended and restated as part of the Exit First Lien Facility, outstanding p (effective 2024-05-07).
“On the Effective Date, (x) the DIP Credit Agreement was amended and restated as part of the Exit First Lien Facility described below such that the outstanding principal amount due on the DIP Facility was reduced to $30 million and (y) $20 million of the DIP Facility Claims were converted into 100% of the New Common Stock of Reorganized Amyris.”
AMYRIS, INC.
AMYRIS, INC. entered into Amended and Restated Loan Agreement (Exit First Lien Facility) with Euagore, LLC valued at up to $160 million aggregate principal amount (effective 2024-05-07).
“the Company, AB Technologies LLC, and Aprinnova, LLC (collectively, the “ Borrowers ”), and certain other subsidiaries of the Company (the “ Guarantors ”) entered into an Amended and Restated Loan Agreement (the “ Exit First Lien Facility ”), dated as of the Effective Date (as amended, restated, supplemented or otherwise modified from time to time), by and among the Borrowers, Guarantors, each lender from time to time party thereto (the “ Lenders ”) and Euagore, LLC, an affiliate of Foris Ventures LLC, in its capacity as administrative agent.”
CPSCooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc. amended Amendment No. 4 with certain lenders, Bank of America, N.A., as agent (effective 2024-05-06).
“(“CSA”), Cooper-Standard Automotive Canada Limited (the “Canadian Borrower”, and, together with CSA, the “Borrowers”) entered into Amendment No. 4 (the “Fourth Amendment”) to the Third Amended and Restated Loan Agreement (as amended, the “Credit Agreement”) with certain lenders, Bank of America, N.A., as agent (the “Agent”), and other parties thereto.”
CTRNCiti Trends Inc
Citi Trends Inc terminated Stockholder Protection Rights Agreement with Equiniti Trust Company, LLC (effective 2024-05-07).
“The Amendment terminated the Rights Agreement by accelerating the expiration time of the Company's preferred share purchase rights”
SCORCOMSCORE, INC.
COMSCORE, INC. amended Amendment with Bank of America, N.A. valued at $40.0 million to $25.0 million (effective 2024-05-03).
“On May 3, 2024, comScore, Inc. (the "Company") entered into an amendment (the "Amendment") to its senior secured revolving credit agreement dated May 5, 2021 (the "Credit Agreement") among the Company, as borrower, the Company's subsidiaries from time to time party thereto, as guarantors, Bank of America, N.A., as administrative agent, and the lenders from time to time party thereto.”
MDGLMADRIGAL PHARMACEUTICALS, INC.
MADRIGAL PHARMACEUTICALS, INC. terminated Prior Sales Agreement with Cowen and Company, LLC (effective 2024-05-07).
“The Sales Agreement replaces and supersedes the prior sales agreement, dated June 1, 2021 and amended on May 9, 2023, between the Company and Cowen and Company, LLC, an affiliate of TD Cowen (the “Prior Sales Agreement”), which was terminated effective upon the entry into the Sales Agreement.”
MDGLMADRIGAL PHARMACEUTICALS, INC.
MADRIGAL PHARMACEUTICALS, INC. entered into Sales Agreement with TD Securities (USA) LLC valued at up to $300,000,000 (effective 2024-05-07).
“On May 7, 2024, Madrigal Pharmaceuticals, Inc. (the “Company”) entered into a Sales Agreement (the “Sales Agreement”) with TD Securities (USA) LLC, (“TD Cowen”), pursuant to which the Company may issue and sell through or to TD Cowen, acting as agent or principal, shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), from time to time having an aggregate sales price of up to $300,000,000 (the “ATM Offering”).”
AVNIARVANA INC
ARVANA INC entered into Consulting Services Agreement with Social4orce, Inc. valued at $50,000 (effective 2024-04-29).
“On April 29, 2024, Arvana Inc. (“Company”) entered into a Consulting Services Agreement (“Agreement”) with Social4orce, Inc. (“Social4orce”) to assist in the development of its business. Social4orce offers expertise in generating a business development strategy, overseeing project management, interpreting market awareness, and accessing capital markets. The Company engaged Social4orce for an initial fee of $50,000”
EVCENTRAVISION COMMUNICATIONS CORP
ENTRAVISION COMMUNICATIONS CORP entered into Share Purchase Agreement with Adsmurai, S.L. and the other stockholders of Adsmurai valued at €15.0 million (approximately $16.2 million) (effective 2024-05-06).
“On May 6, 2024 (the "Effective Date"), Entravision Communications Corporation (the “Company”) entered into a Share Purchase Agreement (the “Purchase Agreement”), among Adsmurai, S.L. ("Adsmurai"), the Company and the other stockholders of Adsmurai (the “Buyers”).”
AGENAGENUS INC
AGENUS INC entered into Purchase Agreement with Ligand Pharmaceuticals Incorporated valued at $75 million (effective 2024-05-06).
“On May 6, 2024, Agenus Inc. (the “Company”), Agenus Royalty Fund, LLC and Agenus Holdings 2024, LLC entered into a Purchase and Sale Agreement (the “Purchase Agreement”) with Ligand Pharmaceuticals Incorporated (“Ligand”) for the sale to Ligand of the following (the “Purchased Assets”)”
PDMPiedmont Realty Trust, Inc.
Piedmont Realty Trust, Inc. amended a credit facility valued at $200 million (effective 2024-05-06).
“On May 6, 2024, Piedmont Operating Partnership, LP, a subsidiary of Piedmont Office Realty Trust, Inc. (the “Registrant”), entered into amendments to the agreements governing its $200 million unsecured 2024 term loan, its $250 million unsecured 2018 term loan and its $600 million unsecured 2022 line of credit.”
LSAKLESAKA TECHNOLOGIES INC
LESAKA TECHNOLOGIES INC entered into Sale Agreement with Adumo (RF) Proprietary Limited valued at ZAR 1.59 billion ($85.9 million) (effective 2024-05-07).
“On May 7, 2024, Lesaka Technologies, Inc. ("Lesaka"), entered into a Sale and Purchase Agreement (the "Sale Agreement") with Lesaka Technologies Proprietary Limited ("Lesaka SA"), and the Sellers (as defined in the Sale Agreement).”
AIFCAI Financial Corp
AI Financial Corp entered into Securities Purchase Agreement with two certain institutional investors valued at approximately $300,000 (effective 2024-05-01).
“On May 1, 2024, JanOne Inc. (the “ Company ” or “ our ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with two certain institutional investors (the “ Investors ”) for the sale by the Company in a registered direct offering priced at-the-market under the rules of The Nasdaq Stock Market (the “ Offering ”) of 79,782 units (the “ Units ”) of the Company’s securities, each Unit consisting of one share of our common stock, par value $0.001 per share (“ Common Stock ”), and one common stock purchase warrant for the purchase of an additional share of Common Stock (“ Warrants ”), at a purchase price of $3.775 per Unit.”
ALLETE INC
ALLETE INC entered into Agreement and Plan of Merger with Alloy Parent LLC and Alloy Merger Sub LLC valued at Merger consideration of $67.00 per share in cash, aggregate equity value approximately $3.9 billion (effective 2024-05-05).
“On May 5, 2024, ALLETE, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”), by and among the Company, Alloy Parent LLC, a Delaware limited liability company (“Parent”), and Alloy Merger Sub LLC, a Delaware limited liability company and wholly owned subsidiary of Parent (“Merger Sub”).”
GXOGXO Logistics, Inc.
GXO Logistics, Inc. entered into Indenture dated as of July 2, 2021, as supplemented by Second Supplemental Indenture dated May 6, 2024 with Computershare Trust Company, N.A. (as successor to Wells Fargo Bank, National Association) valued at $1.1 billion aggregate principal amount of senior notes ($600 million 2029 notes at 6.250% and $500 (effective 2024-05-06).
“On May 6, 2024, GXO Logistics, Inc. (“ GXO ”) completed its previously announced offering of $1.1 billion in aggregate principal amount of senior notes, consisting of $600 million in aggregate principal amount of notes due 2029 (the “ 2029 notes ”) and $500 million in aggregate principal amount of notes due 2034 (the “ 2034 notes ”, and together with the 2029 notes, the “ notes ”). The notes were issued pursuant to an indenture dated as of July 2, 2021 (the “ Base Indenture ”), as supplemented by the Second Supplemental Indenture dated as of May 6, 2024 (the “ Supplemental Indenture ”, and the Base Indenture as amended or supplemented by the Supplemental Indenture, the “ Indenture ”), in each case between GXO and Computershare Trust Company, N.A. (as successor to Wells Fargo Bank, National Association), as trustee (the “ Trustee ”).”
Collective Audience, Inc.
Collective Audience, Inc. entered into Exercise Price Reset Agreement with certain accredited investors (effective 2024-04-26).
“On April 26, 2024 (the "Execution Date"), the Company entered into an Exercise Price Reset Agreement (the "Reset Agreement") with the Investors from the February Private Placement and December Private Placement pursuant to which, among other things, the Company agreed to reset the exercise price of the February Investor’s February Warrants from $5.00 per share of the Company’s common stock, par value $0.0001 (“Common Stock”), to $0.185 per share of Common Stock (the “Reset Exercise Price”) and to reset the December Investor’s December Warrants from an exercise price of $2.13 per share of Common Stock to the Reset Exercise Price.”
BURUNuburu, Inc.
Nuburu, Inc. entered into Pre-Funded Warrant Purchase Program with strategic investors valued at $15 million (effective 2024-05-01).
“Nuburu, Inc. (the “Company”) entered into a Pre-Funded Warrant Purchase Program (the “Program”), effective as of May 1, 2024, with strategic investors, pursuant to which from time-to-time the Company may sell and the investors may acquire pre-funded warrants, up to a total purchase price to the Company equal to $15 million.”
ALITAlight, Inc. / Delaware
Alight, Inc. / Delaware entered into Cooperation Agreement with Starboard Value and Opportunity Master Fund, Ltd. valued at Board appointments, standstill restrictions, expense reimbursement up to $625,000 (effective 2024-05-06).
“On May 6, 2024, Alight, Inc., a Delaware corporation (the “Company”), announced its entry into a cooperation agreement (the “Cooperation Agreement”) with Starboard Value and Opportunity Master Fund, Ltd. (together with its affiliates, “Starboard”).”
NXTTNext Technology Holding Inc.
Next Technology Holding Inc. entered into Bitcoin Option Contract with Seller valued at Company may purchase up to 20,000 BTC at US$60,000 per BTC, locked for three years, with payment in (effective 2024-05-02).
“T Cover a 12-month period from a specified seller (“Seller”). As of the signing date of the Amendment, the Company had purchased”
NXTTNext Technology Holding Inc.
Next Technology Holding Inc. amended Amendment Agreement to BTC Trading Contract with Seller valued at Consideration consists of 40,000,000 shares of common stock and 80,000,000 warrant shares; total BTC (effective 2024-05-02).
“On May 2, 2024, Next Technology Holding Inc. (formerly known as WeTrade Group Inc.), a Wyoming corporation (“Company”), entered into an Amendment Agreement(“Amendment”) to a BTC Trading Contract.”
Kiromic Biopharma, Inc.
Kiromic Biopharma, Inc. entered into 25% Senior Secured Convertible Promissory Note with an accredited investor valued at $2,000,000 (effective 2024-05-01).
“On May 1, 2024, Kiromic BioPharma, Inc. (the “Company”) issued a 25% Senior Secured Convertible Promissory Note (the “Note”) to an accredited investor.”
AOMRAngel Oak Mortgage REIT, Inc.
Angel Oak Mortgage REIT, Inc. amended Amended and Restated Management Agreement with Falcons I, LLC (effective 2024-05-01).
“On May 1, 2024, Angel Oak Mortgage REIT, Inc. (the "Company"), Angel Oak Mortgage Operating Partnership, LP, the Company's operating partnership, and Falcons I, LLC, the Company's external manager (the "Manager") amended and restated that certain Management Agreement dated as of June 21, 2021 to (i) clarify (a) the officers and employee(s) provided by the Manager that will be fully or partially dedicated to the Company and (b) the related full or partial reimbursements to the Manager for their salaries and other benefits, subject to the approval of the Compensation Committee, and (ii) update the names of various entities and make certain other minor updates.”
CGCCanopy Growth Corp
Canopy Growth Corp entered into Exchange and Subscription Agreement with MMCAP International Inc. SPC valued at approximately C$27.5 million aggregate principal amount of Supreme Debentures (effective 2024-05-02).
“On May 2, 2024, the Company entered into an Exchange and Subscription Agreement (the “ Exchange and Subscription Agreement ”) with MMCAP International Inc. SPC (the “ Investor ”) pursuant to which, among other things, the Investor agreed to deliver to the Company approximately C$27.5 million aggregate principal amount of Supreme Debentures maturing in September 2025 held by the Investor and pay the Company approximately US$50 million in exchange for the Company issuing to the Investor (i) a new senior unsecured convertible debenture of the Company with an aggregate principal amount of C$96,358,375”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.